PTC Therapeutics, Inc. (PTCT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.04B |
| Enterprise Value | 7.76B |
| P/E Ratio | -49.37 |
| PEG Ratio | 0.7 |
| Price/Sales Ratio | 4.68 |
| Price/Book Ratio | -28.23 |
| Enterprise/Revenue | 4.79 |
| Enterprise/EBITDA | 31.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.09 |
| Operating Margin | 0.12 |
| Return On Assets | -0.03 |
| Return On Equity | 0.57 |
| Revenue | 1.73B |
| Revenue/Share | 13.84 |
| Gross Profit | 1.66B |
| EBITDA | 887.66M |
| Net Income | 682.64M |
| Diluted EPS | 7.78 |
| Total Cash | 2.13B |
| Total Cash/Share | 25.49 |
| Total Debt | 636.03M |
| Total Debt/Equity | -3.33 |
| Current Ratio | 3.27 |
| Book Value Per Share | -2.29 |
| 52-Week Change | -12.4 |
| 52-Week High | 90.87 |
| 52-Week Low | 58.8 |
| Moving Average 50 Days | 64.56 |
| Moving Average 200 Days | 70.34 |
| Average Volume | 1.09M |
| Shares Outstanding | 83.54M |
| % Held by Institutions | 122.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |